Preclinical Stroke Research and Translational Failure: A Bird’s Eye View on Preventable Variables

Autor: Kh. Reeta, Devendra Singh, Himika Wasan
Rok vydání: 2021
Předmět:
Zdroj: Cellular and Molecular Neurobiology. 42:2003-2017
ISSN: 1573-6830
0272-4340
DOI: 10.1007/s10571-021-01083-6
Popis: Despite achieving remarkable success in understanding the cellular, molecular and pathophysiological aspects of stroke, translation from preclinical research has always remained an area of debate. Although thousands of experimental compounds have been reported to be neuro-protective, their failures in clinical setting have left the researchers and stakeholders in doldrums. Though the failures described have been excruciating, they also give us a chance to refocus on the shortcomings. For better translational value, evidences from preclinical studies should be robust and reliable. Preclinical study design has a plethora of variables affecting the study outcome. Hence, this review focusses on the factors to be considered for a well-planned preclinical study while adhering to guidelines with emphasis on the study design, commonly used animal models, their limitations with special attention on various preventable attritions including comorbidities, aged animals, time of dosing, outcome measures and physiological variables along with the concept of multicentric preclinical randomized controlled trials. Here, we provide an overview of a panorama of practical aspects, which could be implemented, so that a well-defined preclinical study would result in a neuro-protectant with better translational value.
Databáze: OpenAIRE
Externí odkaz: